Legend Biotech Corporation
LEGN
$34.18
-$0.52-1.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -348.13M | -285.01M | -465.95M | -518.25M | -509.31M |
| Total Depreciation and Amortization | 19.87M | 19.38M | 19.01M | 18.53M | 18.05M |
| Total Amortization of Deferred Charges | 2.05M | 2.23M | 1.98M | 1.92M | 2.30M |
| Total Other Non-Cash Items | 79.99M | 17.32M | 141.01M | 177.19M | 149.04M |
| Change in Net Operating Assets | 88.63M | 103.46M | 65.40M | -72.67M | -7.45M |
| Cash from Operations | -157.60M | -142.63M | -238.54M | -393.28M | -347.37M |
| Capital Expenditure | -16.07M | -19.38M | -22.06M | -20.08M | -22.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -53.00K | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -339.12M | -873.96M | -297.29M | 112.87M | -267.50M |
| Cash from Investing | -355.19M | -893.34M | -319.39M | 92.79M | -289.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.78M | -3.34M | -3.70M | -3.76M | -5.47M |
| Issuance of Common Stock | 9.73M | 7.01M | 796.46M | 795.25M | 795.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.96M | 3.67M | 792.77M | 791.49M | 789.78M |
| Foreign Exchange rate Adjustments | 1.64M | 336.00K | 2.69M | 682.00K | -1.88M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -504.19M | -1.03B | 237.52M | 491.68M | 150.74M |
